ファビピラビル

Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial
 Chen C, et al.〔medRxiv. 2020 Mar 17〕（査読前）


Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
 Cai Q, et al.〔Engineering. 2020 Mar 18〕（査読済み）

AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II/III Multicenter Randomized Clinical Trial
 Ivashchenko AA, et al.〔Clin Infect Dis. 2020 Aug 9;ciaa1176〕（査読済み）

Early favipiravir treatment was associated with early defervescence in non-severe COVID-19 patients
 Fujii S, et al.〔J Infect Chemother. 2021 Apr 17;27(7):1051-1057〕（査読済み）